Dramatic response of metaplastic breast cancer to chemo-immunotherapy
Abstract Frequent overexpression of programmed death-ligand 1 has recently been demonstrated in metaplastic breast cancer, which is a rare breast cancer subtype with limited treatment options. This report describes the clinical course of a patient with metastatic metaplastic breast cancer who had a...
Guardado en:
Autor principal: | Sylvia Adams |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f7d023da910243e7ba102aee3fa471ff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Willard Wong, et al.
Publicado: (2021) -
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer
por: Edaise M. da Silva, et al.
Publicado: (2021) -
An Update on the Molecular Pathology of Metaplastic Breast Cancer
por: McCart Reed AE, et al.
Publicado: (2021) -
Immunotherapy in breast cancer: A clinician's perspective
por: Sibapriya Chaudhuri, et al.
Publicado: (2021) -
Cancer immunology and immunotherapy
por: Xiubao Ren
Publicado: (2021)